MD Start
Venture capital · Paris, France · Europe
MD Start is a medical device company builder that combines a seed fund, an incubator and an entrepreneurial team. It creates, develops and operates medtech projects from physician and researcher inventions, turning them into new companies.
Invests inHealthcare & Biotech
In its own wordsmedtechmedical devicescompany buildingincubationhealthcare
Your fit with MD Start
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMD Start lists 10 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (91%) and Media & Entertainment (9%). 80% of its companies are based in France. It invests most often alongside Sofinnova Partners, Agoranov and Asabys Partners.
No funding round on record names MD Start yet, so the figures come from its portfolio page.
Round figures show recent activity, not MD Start's whole history. Rounds on record name 0 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 96th | 91% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers10100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 91% | 15% |
| Media & Entertainment | 9% | 4% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Sofinnova Partners
Compare MD Start head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its sitePortfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| CorWave is a clinical-stage medical device company that develops implantable heart-assist pumps (LVADs) for patients with advanced heart failure. | Healthcare & BiotechMedia & Entertainment | Portfolio page | ||
| Endoron Medical develops anchoring solutions for transcatheter endovascular treatments, including TAVR and EVAR. | Healthcare & Biotech | Portfolio page | ||
| Gradient Denervation Technologies develops a minimally invasive, ultrasound-based device for the treatment of pulmonary hypertension. | Healthcare & Biotech | Portfolio page | ||
| HEPTA Medical develops a microwave ablation platform for medical procedures | Healthcare & Biotech | Portfolio page | ||
| LimFlow provides a medical procedure for patients | Healthcare & Biotech | Portfolio page | ||
| May Health provides services related to healthcare for patients and professionals. | Healthcare & Biotech | Portfolio page | ||
| MD Start creates, develops and operates medical technology projects, turning them into new companies | Healthcare & Biotech | Portfolio page | ||
| Moon Surgical develops and markets a robotic system for surgical assistance | Healthcare & Biotech | Portfolio page | ||
| SafeHeal is a clinical stage medical device manufacturer that develops anastomosis protection devices for colorectal surgery | Healthcare & Biotech | Portfolio page | ||
| Tulyp Medical develops intelligent, pressure-controlled perfusion technologies to preserve tissue viability and improve clinical outcomes for patients with compromised blood flow. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- mdstart.eu
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get MD Start's profile as data
Pull MD Start's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/mdstart.eu
# also
GET /v1/firms/mdstart.eu/portfolio
GET /v1/firms/mdstart.eu/coinvestors
GET /v1/firms/mdstart.eu/news